Price target upside
Lakewood-Amedex Biotherapeutics Price Target: +943.5% vs Current Price
Direct answer
Lakewood-Amedex Biotherapeutics's analyst target implies +943.5%.
The average target is $12.00 compared with a recorded current price of $1.15.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked September 28, 2026.
Get free Lakewood-Amedex Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.15
- Average price target
- $12.00
- High price target
- $12.00
- Low price target
- $12.00
- Low target gap
- +943.5%
- Target upside
- +943.5%
- High target gap
- +943.5%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- September 28, 2026
- Valid through
- October 5, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Lakewood-Amedex Biotherapeutics's average target imply?
Lakewood-Amedex Biotherapeutics's average target is $12.00 versus a recorded price of $1.15. The difference is +943.5%.
How far are Lakewood-Amedex Biotherapeutics's low and high targets from the recorded price?
The low target implies +943.5%, while the high target implies +943.5%.
How many analysts are included in Lakewood-Amedex Biotherapeutics's consensus?
The verified consensus includes 1 analysts.
How is Lakewood-Amedex Biotherapeutics's target upside or downside calculated?
The average target of $12.00 is divided by the recorded price of $1.15, then one is subtracted to produce +943.5%. This does not guarantee a future return.
When was Lakewood-Amedex Biotherapeutics's analyst forecast verified?
The data was verified on 2026-09-28. The dataset is valid through 2026-10-05.